These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18174545)

  • 1. Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation.
    Bobadilla JL; Love RB; Jankowska-Gan E; Xu Q; Haynes LD; Braun RK; Hayney MS; Munoz del Rio A; Meyer K; Greenspan DS; Torrealba J; Heidler KM; Cummings OW; Iwata T; Brand D; Presson R; Burlingham WJ; Wilkes DS
    Am J Respir Crit Care Med; 2008 Mar; 177(6):660-8. PubMed ID: 18174545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejection.
    Braun RK; Molitor-Dart M; Wigfield C; Xiang Z; Fain SB; Jankowska-Gan E; Seroogy CM; Burlingham WJ; Wilkes DS; Brand DD; Torrealba J; Love RB
    Transplantation; 2009 Dec; 88(12):1341-8. PubMed ID: 20029330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction.
    Iwata T; Philipovskiy A; Fisher AJ; Presson RG; Chiyo M; Lee J; Mickler E; Smith GN; Petrache I; Brand DB; Burlingham WJ; Gopalakrishnan B; Greenspan DS; Christie JD; Wilkes DS
    J Immunol; 2008 Oct; 181(8):5738-47. PubMed ID: 18832733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants.
    Burlingham WJ; Love RB; Jankowska-Gan E; Haynes LD; Xu Q; Bobadilla JL; Meyer KC; Hayney MS; Braun RK; Greenspan DS; Gopalakrishnan B; Cai J; Brand DD; Yoshida S; Cummings OW; Wilkes DS
    J Clin Invest; 2007 Nov; 117(11):3498-506. PubMed ID: 17965778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen type-V is a danger signal associated with primary graft dysfunction in lung transplantation.
    Zaffiri L; Shah RJ; Stearman RS; Rothhaar K; Emtiazjoo AM; Yoshimoto M; Fisher AJ; Mickler EA; Gartenhaus MD; Cohort LTOG; Diamond JM; Geraci MW; Christie JD; Wilkes DS
    Transpl Immunol; 2019 Oct; 56():101224. PubMed ID: 31325493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential requirement for P2X7R function in IL-17 dependent vs. IL-17 independent cellular immune responses.
    Sullivan JA; Jankowska-Gan E; Shi L; Roenneburg D; Hegde S; Greenspan DS; Wilkes DS; Denlinger LC; Burlingham WJ
    Am J Transplant; 2014 Jul; 14(7):1512-22. PubMed ID: 24866539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection.
    Haque MA; Mizobuchi T; Yasufuku K; Fujisawa T; Brutkiewicz RR; Zheng Y; Woods K; Smith GN; Cummings OW; Heidler KM; Blum JS; Wilkes DS
    J Immunol; 2002 Aug; 169(3):1542-9. PubMed ID: 12133982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection.
    Tiriveedhi V; Angaswamy N; Brand D; Weber J; Gelman AG; Hachem R; Trulock EP; Meyers B; Patterson G; Mohanakumar T
    Clin Exp Immunol; 2012 Jan; 167(1):158-68. PubMed ID: 22132895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metalloproteinase inhibition has differential effects on alloimmunity, autoimmunity, and histopathology in the transplanted lung.
    Yoshida S; Iwata T; Chiyo M; Smith GN; Foresman BH; Mickler EA; Heidler KM; Cummings OW; Fujisawa T; Brand DD; Baker A; Wilkes DS
    Transplantation; 2007 Mar; 83(6):799-808. PubMed ID: 17414715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants.
    Yoshida S; Haque A; Mizobuchi T; Iwata T; Chiyo M; Webb TJ; Baldridge LA; Heidler KM; Cummings OW; Fujisawa T; Blum JS; Brand DD; Wilkes DS
    Am J Transplant; 2006 Apr; 6(4):724-35. PubMed ID: 16539629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral tolerance induction by type V collagen downregulates lung allograft rejection.
    Yasufuku K; Heidler KM; O'Donnell PW; Smith GN; Cummings OW; Foresman BH; Fujisawa T; Wilkes DS
    Am J Respir Cell Mol Biol; 2001 Jul; 25(1):26-34. PubMed ID: 11472972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope analysis of the collagen type V-specific T cell response in lung transplantation reveals an HLA-DRB1*15 bias in both recipient and donor.
    Keller MR; Haynes LD; Jankowska-Gan E; Sullivan JA; Agashe VV; Burlingham SR; Burlingham WJ
    PLoS One; 2013; 8(11):e79601. PubMed ID: 24265781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis.
    Vittal R; Mickler EA; Fisher AJ; Zhang C; Rothhaar K; Gu H; Brown KM; Emtiazjoo A; Lott JM; Frye SB; Smith GN; Sandusky GE; Cummings OW; Wilkes DS
    PLoS One; 2013; 8(10):e76451. PubMed ID: 24204629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance.
    Yasufuku K; Heidler KM; Woods KA; Smith GN; Cummings OW; Fujisawa T; Wilkes DS
    Transplantation; 2002 Feb; 73(4):500-5. PubMed ID: 11889419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung transplant ischemia reperfusion injury: metalloprotease inhibition down-regulates exposure of type V collagen, growth-related oncogene-induced neutrophil chemotaxis, and tumor necrosis factor-alpha expression.
    Iwata T; Chiyo M; Yoshida S; Smith GN; Mickler EA; Presson R; Fisher AJ; Brand DD; Cummings OW; Wilkes DS
    Transplantation; 2008 Feb; 85(3):417-26. PubMed ID: 18322435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing S1P1 receptors regulates collagen-V reactive lymphocyte-mediated immunobiology in the transplanted lung.
    Chiyo M; Iwata T; Webb TJ; Vasko MR; Thompson EL; Heidler KM; Cummings OW; Yoshida S; Fujisawa T; Brand DD; Wilkes DS
    Am J Transplant; 2008 Mar; 8(3):537-46. PubMed ID: 18294150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of Smad7 transcripts identifies the CD4+CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts.
    Mizobuchi T; Yasufuku K; Zheng Y; Haque MA; Heidler KM; Woods K; Smith GN; Cummings OW; Fujisawa T; Blum JS; Wilkes DS
    J Immunol; 2003 Aug; 171(3):1140-7. PubMed ID: 12874199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection.
    Bharat A; Saini D; Steward N; Hachem R; Trulock EP; Patterson GA; Meyers BF; Mohanakumar T
    Ann Thorac Surg; 2010 Oct; 90(4):1094-101. PubMed ID: 20868794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts.
    Yamada Y; Sekine Y; Yoshida S; Yasufuku K; Petrache I; Benson HL; Brand DD; Yoshino I; Wilkes DS
    J Immunol; 2009 Jul; 183(1):237-45. PubMed ID: 19542435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflux-induced collagen type v sensitization: potential mediator of bronchiolitis obliterans syndrome.
    Bobadilla JL; Jankowska-Gan E; Xu Q; Haynes LD; Munoz del Rio A; Meyer K; Greenspan DS; De Oliveira N; Burlingham WJ; Maloney JD
    Chest; 2010 Aug; 138(2):363-70. PubMed ID: 20418369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.